^
Association details:
| Biomarker: | LINC00963 overexpression |
|---|---|
| Cancer: | Gastric Cancer |
| Drug: | oxaliplatin (DNA synthesis inhibitor, DNA cross linking agent) |
| Direction: | Resistant |
Evidence:
Source:
Title:
LINC00963: A potential cancer diagnostic and therapeutic target
Published date:
04/21/2022
Excerpt:
Aberrantly upregulated LINC00963 was significantly associated with resistance to cisplatin/5-fluorouracil and oxaliplatin in oral squamous cell carcinoma and gastric cancer, respectively….LINC00963 is expected to become a new marker and therapeutic target of cancer.
DOI:
10.1016/j.biopha.2022.113019
